Amerant Bancorp

AMTB · NYSE

$29.06+$0.56 (+1.96%)TodayMarket closed · Oct 20, 7:00 PM ET

Prev close $28.50

AMTB analyst rating

BuyConsensus of 4 analysts over the last 12 months. 50% rate it a buy.

Strong buy0
Buy2
Hold2
Underperform0
Sell0

12-month price target · 6 analysts

Average $32.51 (+11.9% upside)

Low: $31.31
Now: $29.06
High: $35.17

Upgrades and downgrades

The latest rating actions, newest first

AMTB analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Stephens & Co.	Aug 12, 2026	Downgrade	Overweight → Equal-Weight	—	—
Keefe, Bruyette & Woods	Aug 3, 2026	Maintains	Market Perform	$26.00 → $31.00	79%
Keefe, Bruyette & Woods	Jan 28, 2026	Maintains	Market Perform	$21.00 → $23.00	79%
Piper Sandler	Jan 26, 2026	Maintains	Overweight	$22.00 → $25.00	67%
Raymond James	Jan 7, 2026	Maintains	Outperform	$21.00 → $23.00	61%
Keefe, Bruyette & Woods	Nov 3, 2025	Maintains	Market Perform	$22.00 → $20.00	79%
Raymond James	Oct 29, 2025	Upgrade	Market Perform → Outperform	$21.00	61%
Piper Sandler	Oct 29, 2025	Maintains	Overweight	$26.00 → $22.00	67%

The case for and against

Updated Apr 17, 2026

Bull case

Amerant Bancorp demonstrated resilience with a 3.5% quarter-over-quarter growth in tangible book value per share (TBVPS) and anticipates a return on assets (ROA) of 80-90 basis points for the fourth quarter of 2025. The bank expects organic deposit growth to align with an estimated 2.5% loan growth in the coming quarter, supporting its financial stability and expansion strategy. Additionally, management has initiated efficiency measures targeting $2 million to $3 million in quarterly cost savings for 2026, alongside expected recoveries from a recent payoff, which further enhances the potential for improved financial metrics going forward.

Bear case

Amerant Bancorp's loan growth was hindered in the third quarter of 2025 due to elevated payoffs and asset quality-related sales, raising concerns about future net income stability amidst a potential economic slowdown that could increase nonperforming assets. The bank’s reliance on brokered deposits and a challenging loan-to-deposit ratio, which underperforms compared to peers, further complicates its financial outlook. Additionally, the risk of asset quality deterioration coupled with a flat duration in its securities portfolio suggests that a decline in interest rates could significantly impact net interest income, leading to an overall negative sentiment regarding the bank's future financial performance.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.